Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
life sciences
national blog main
startups
3
×
venture capital
3
×
boston top stories
financing
funding
20/20 healthcare partners
akero therapeutics
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
antisense oligonucleotide
apellis pharmaceuticals
aragon pharmaceuticals
benzodiazepines
biogen
blackstone group
blackstone life sciences
christian angermayer
clinical trials
columbia university
corey goodman
david goldstein
depression
dolby family ventures
enclear therapies
epi4k
epilepsy
essential tremor
gf securities
global health sciences fund
harmony biosciences
hillel bachrach
investing
investment
jason camm
What
new
3
×
drugs
neuro
aims
approach
associated
backed
bags
biotechs
capital
cause
ceo
companies
develop
device
dialysis
disease
diseases
enclear
epilepsy
genes
genetic
harmful
investing
investors
led
limited
links
making
marcio
medicine
medicines
mitigated
mutations
nets
neurodegenerative
partners
praxis
precision
proteins
Language
unset
Current search:
new
×
startups
×
boston
×
" venture capital "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device